CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Open-market sale EVP, Drug Development sold 1,529 shares at $17.66 ($27,009)
- 4 Open-market sale Director sold 300 shares at $17.51 ($5,254)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 963 shares (to pay taxes)
- 4 Shares withheld for taxes President & CCO gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 191 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
- 4 Open-market sale Director sold 250 shares at $17.22 ($4,305)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP, Chief Operating Officer sold 827 shares at $18.09 ($14,960)
- 4 Shares withheld for taxes Chief Executive Officer gave up 963 shares (to pay taxes)
- 4 Shares withheld for taxes President & CCO gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 227 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
- 4 Open-market sale EVP, Chief Operating Officer sold 3,571 shares at $19.66 ($70,219)
- 4 Other acquisition President & CCO acquired 637 shares (other)
- 4 Open-market sale EVP, Drug Development sold 10,000 shares at $20.00 ($200,000)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
Page 11 of 30 · 585 filings